MD | Research Fellow @Cambridge_uni | Senior Kidney Cancer Fellow @CUH_NHS | Resident in Urology @SanRaffaeleMI | Associate Member @EAUYAU_RenalCa
Joined April 2022
- Tweets83
- Following346
- Followers189
- Likes476
Chiara Re retweeted
🇮🇹 Gli Azzurri are coming for the Uromigos World Cup! ⚽🏆
From the Duomo di Milano to the latest in bladder preservation, Team Italy is bringing the Milan criteria for clinical complete response to the pitch.
And they've got a message for the competition: We're coming for you! 👀
🎥 : @giannatempopatr & @CMercinelli | #UromigosLive
Just back from the 99th National Congress of the Italian Society of Urology in Riccione #SIU2026
Privileged to have been faculty of a course on localised & metastatic RCC, and to share my last congress as a resident with my @SanRaffaeleMI colleagues
See you in Rome for the 100th!
Chiara Re retweeted
#ESMO26 Urothelial carcinoma reflections and implications for kidney cancer @grantissimus @urotoday
Ph 2 International Neoadjuvant Kidney Cancer Collaboration Master Protocol @innovativectu
SOC: 12 mos adjuvant pembro
Goal: Evaluate multiple neoadjuvant strategies
And just like that, my kidney cancer fellowship at @CUH_NHS has come to an end.
240+ cases, countless clinics and MDTs, publications, and an amazing team who made Cambridge feel like home.
Forever grateful for this unforgettable year!
@grantissimus @Tom_J_Mitchell @MaxineGBTran
Chiara Re retweeted
10 Must-Read Posts in GU Oncology This Week | September 28–October 4
This week’s GU oncology selection covers prostate cancer, RCC, bladder cancer, penile cancer, and testicular tumors.
Highlights include:
• BCG-unresponsive CIS trial design
• PSA kinetics after radiotherapy
• DEPECA penile cancer trial recruitment
• uRARE-Seq liquid biopsy in bladder cancer
• Apalutamide progression patterns in mCSPC
• PURE01 vs KEYNOTE-905 in MIBC
• KEYNOTE-427 final data in ccRCC/nccRCC
• TroFuse055 bladder-preservation trial
• The 3-cm rule in papillary RCC
• Metabolic and muscular profiling in testicular tumors
@AlbertoMartini_ @Soum_Roy_RadOnc @Igor__Tsaur @AshAlizadeh @katy_beckermann @AndreaNecchi @drenriquegrande @sonpavde @ChiaraRe @ogarrieta
oncodaily.com/genitourinary-…
#OncoDaily #GUOncology
📢 New editorial out in @EurUrolOncol!
Rethinking the 3-cm rule in #RCC: is size enough?
Long-term evidence in sporadic bilateral multifocal pRCC suggests that when we intervene may be as important as how.
Great pleasure to work with @Selcuk__Erdem & @u_capitanio
What an inspiring day at the Urological Cancers Symposium hosted by @CRUK_CI. Feeling extremely grateful for the opportunity to share thoughts, insights and perspectives with exceptional leaders who are truly transforming the future of cancer care.
@CRUKCamUrol @Cambridge_Uni
Chiara Re retweeted
Carbonic anhydrase IX-PET deciphers intra-tumor heterogeneity of #renalcancer: first-in-human ex-vivo validation in high-risk ccRCC ☢️ 🩻 🔬
Full paper published in @THNOdotORG available at thno.org/v16p6980.htm
Grateful to be funded by @MinisteroSalute and @EU_Commission – NextGenerationEU 🇪🇺 | PNRR M6C2 – PNRR-POC-2023-12377493
#kidneycancer #NucMed #theranostics
Not every oligometastatic #RCC recurrence needs immediate ST
In selected pts, AS or metastasis-directed therapy may offer valuable time off ST-with no survival disadvantage
The goal is not to identify the best strategy, but the right strategy for the right patient @SanRaffaeleMI
Do positive surgical margins matter after partial nephrectomy?
1,441 pts treated over 24 years for #RCC (5.6% PSM)
🔬4-fold higher risk of local recurrence
🎯No significant association with systemic progression/CSM/OM
👀Supporting careful postoperative surveillance
@SanRaffaeleMI
Chiara Re retweeted
🔬 Does biological sex influence kidney cancer outcomes more than we currently recognize?
sciencedirect.com/science/ar…
Sex-based differences in peri-operative and long-term oncologic outcomes after primary surgical treatment for kidney cancer: A comprehensive analysis from a high-volume tertiary center
A contemporary cohort of 3,956 patients undergoing #KidneyCancer surgery found meaningful sex-related♀️ ♂️ differences in peri-operative and tumor characteristics.
✅ After adjustment, men had longer operative times, 📈 higher postoperative acute kidney injury risk, and greater odds of high-grade tumors and necrosis. Male sex was also associated with progression at unfavorable metastatic sites. However, sex was not independently associated with relapse-free, progression-free, or overall survival, highlighting complex biological and clinical differences.
@FedericoBellad1
@Albert0Briganti
@gaspare2006
@profmontorsi
@_alelarcher
Does sex matter in kidney cancer surgery?
~4,000 pts underwent nephrectomy for #RCC over 30 years (31% women)
👨 Men had:
⏱️ Longer op times & 49% higher risk of postop AKI
🔬 More high-grade tumours & necrosis
🎯 Higher risk of unfavourable metastatic progression
@SanRaffaeleMI
Chiara Re retweeted
Cystectomy Can Be Spared in Selected Patients with Muscle-invasive Bladder Cancer and Complete Response Following Neoadjuvant Therapy - @EUplatinum @OncoAlert @urotoday #cCR @IBCG_BladderCA #Milancriteria @SanRaffaeleMI @MyUniSR europeanurology.com/article/…
The crucial role of renal tumour biopsy in #RCC highlighted once again through a huge collaborative effort by @EAUYAU_RenalCa and leading experts. Proud to be part of this fantastic team!
@Euplatinum
doi: doi.org/10.1016/j.eururo.202…
🎯 #YAU_RCC on @EurUrol
📌 SR & MA on Renal Tumor Biopsy
🔎 Yield 90% | Sens 99% | Concordance benign vs malignant 96% | Complications 3% | Management changed in 39%
🔗 doi: doi.org/10.1016/j.eururo.202…
✍️ @GeorgesMjaess @CPalumbo87 @grantissimus @foxal72
@EUplatinum @Uroweb
Chiara Re retweeted
⚡️ Updated NICE 2026 guideline on kidney cancer: a comprehensive pathway from suspicion to risk-adapted treatment and follow-up.
87% of stage 1a RCC in the UK is diagnosed incidentally. A reminder of how challenging early detection remains in everyday clinical practice.
thelancet.com/journals/lanon…
#KidneyCancer @OncoAlert
Chiara Re retweeted
#YAU_RenalCancerSpotlight No. 10
📌Editorial on the GBD 2021 study (Eur Urol Oncol): RCC incidence rising, mortality falling - a call to action for early detection & screening
doi.org/10.23736/S2724-6051.…
📖 @MUN_journal
✍️ @ChiaraRe @Ric_Campi @danieleamparore
@EUplatinum @Uroweb
Chiara Re retweeted
More great data supporting #activesurveillance for very small <2cm renal masses
excellent safety & longterm follow-up from 🇮🇹 colleagues! @u_capitanio et al
the N=1 patient who developed mets did so with rapid growth and mass >3cm
rdcu.be/fihJ1 @wjurol #kidneycancer
Chiara Re retweeted
A must-read comment by great @EAUYAU_RenalCa team, @Ric_Campi @danieleamparore
@Nature Reviews Urology comment argues for a practical shift: understand complexity, embrace uncertainty, and use shared decision-making to avoid both overtreatment and undertreatment.
🔗rdcu.be/fgo1e
@OncoAlert #cancer #Oncology #kidneycancer
